Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Aulos Bioscience, Inc.
Aulos Bioscience, Inc.
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
TILT Biotherapeutics Ltd.
Groupe Oncologie Radiotherapie Tete et Cou
University of California, San Diego
Gruppo Oncologico del Nord-Ovest
Genome & Company
Presage Biosciences
Pfizer
Pfizer
The Netherlands Cancer Institute